Welcome to iCeutica

Focused on rapidly transforming and launching pharmaceuticals.

iCeutica develops new pharmaceuticals and creates valuable new companies using its proprietary SoluMatrix™ formulation technology. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route.

iCeutica has created franchises in several different therapeutic areas which it is developing itself and in collaboration with select partners. Products which have been formulated using SoluMatrix™ are now finishing Phase 3 trials and are being prepared for NDA filings. We also have a number of products in Phase 1 and Phase 2 in addition to a pipeline of new opportunities being readied for clinical development.

Our goal is to make drugs that are preferred by patients and providers globally.

SoluMatrix™ Technology > Pipeline > Our team >